Durezol difluprednate: Preliminary Phase III data

Preliminary data from a 6-week, double-blind, U.S. Phase III study (ST-601A-001) in 90 patients with endogenous anterior uveitis showed that 4-times-daily Durezol was noninferior to 8-times-daily Pred...